Editorial

Leukemia Research is further developing its goal of bringing comprehensive and current information to all health care professionals involved in basic research and/or applied clinical research both in leukemias and other hematologic malignancies. The editors encourage the submission of articles relevant to normal and leukemic hemopoiesis, biochemistry, cell biology, immunology, molecular biology as well as epidemiologic and clinical studies and specifically of major interest, articles that encompass the application of oncogenes, growth factors, cell markers, cell cycle and differentiation agents, novel therapeutics and clinical trials in both the acute and chronic leukemias as well as the myelodysplastic syndromes. In addition articles are welcomed on the rapidly increasing specialty of marrow or stem cell reconstitution after high dose therapy with curative attempt in patients with a wide range of neoplasms.

Audience

Medical scientists, haematologists, immunologists, oncologists and chemotherapists.

Publishing Staff

John M. Bennett, Medical Oncology Unit, University of Rochester Medical Center, Rochester, NY, USA.
Terry J. Hamblin, Consultant Haematologist, Royal Bournemouth Hospital, Bournemouth, UK.

Frequency

12 issues/year

Homepage

http://intl.elsevierhealth.com/journals/lere/

For supplement sponsor information.

Back to Top

Product Advertising Sales John Marmero Elsevier 360 Park Avenue South New York, NY 10010 Tel: 212-633-3657 Fax: 212-633-3820 j.marmero@elsevier.com	European & International Product Sales Emma Steel Elsevier Tel: +44 (0) 207 424 4221 Fax: +44 (0) 207 424 4431 e.steel@elsevier.com
Reprints Anna Rosenthal Elsevier 360 Park Avenue South New York, NY 10010 Tel: 212-633-3812 Fax: 212-633-3820 reprints@elsevier.com	Supplements Emma Steel Elsevier Tel: +44 (0) 207 424 4221 Fax: +44 (0) 207 424 4431 e.steel@elsevier.com